
Hermetica Superfood Encyclopedia
Legacy index-continuity record: the score and narrative are provisional and must not be represented as validated or human-approved.
Review flags: AWAITING_SEMANTIC_VALIDATION
Phenibut (β-phenyl-GABA) is a synthetic derivative of GABA that crosses the blood-brain barrier to enhance GABAergic neurotransmission. It acts primarily on GABA-B receptors and voltage-gated calcium channels to produce anxiolytic and nootropic effects.

Reported Benefits (Provisional)
Origin & History

Phenibut is a synthetic derivative of the neurotransmitter GABA, originally developed in Russia in the 1960s. It is produced through the chemical modification of GABA, adding a phenyl ring to enhance its ability to cross the blood-brain barrier.
Research Narrative (Provisional)
Phenibut has been studied in various clinical settings, primarily in Russia, with some human trials indicating its efficacy for anxiety and sleep disorders. However, comprehensive RCTs in Western countries are limited.
Preparation & Dosage
Dosage guidance is withheld because the publication gate has not recorded adequate support for this profile.
Nutritional Profile
- Not naturally occurring; synthesized from GABA. - Typically available in powder or capsule form. - Often dosed in milligrams, with specific formulations for therapeutic use.
Reported Mechanism (Provisional)
Phenibut binds to GABA-B receptors with high affinity, increasing inhibitory neurotransmission in the central nervous system. It also blocks voltage-gated calcium channels, particularly α2δ subunits, reducing excitatory neurotransmitter release. The phenyl group enables blood-brain barrier penetration, unlike natural GABA.
Clinical Narrative (Provisional)
Human studies on phenibut are limited, with most research conducted in Russia and Eastern Europe. Small clinical trials (20-50 participants) suggest anxiolytic effects at 250-750mg daily doses. Animal studies demonstrate improved stress tolerance and cognitive performance, but large-scale randomized controlled trials are lacking. Evidence quality remains moderate due to limited Western research and potential publication bias.
Also Known As
Research updates — and 25% off your first order
Join our list for source-aware wellness education, review-state updates, and product news — and unlock 25% off your first Hermetica order. Educational content is not medical advice. No spam, unsubscribe anytime.







